Welcome to the InfoSci Platform
Offshoring in the Pharmaceutical Industry

Offshoring in the Pharmaceutical Industry

Jason McCoy, Johannes Sarx
Copyright: © 2008 |Volume: 1 |Issue: 2 |Pages: 16
ISSN: 1938-7857|EISSN: 1938-7865|ISSN: 1938-7857|EISBN13: 9781615205479|EISSN: 1938-7865|DOI: 10.4018/jitr.2008040103
Cite Article Cite Article

MLA

McCoy, Jason, and Johannes Sarx. "Offshoring in the Pharmaceutical Industry." JITR vol.1, no.2 2008: pp.38-53. http://doi.org/10.4018/jitr.2008040103

APA

McCoy, J. & Sarx, J. (2008). Offshoring in the Pharmaceutical Industry. Journal of Information Technology Research (JITR), 1(2), 38-53. http://doi.org/10.4018/jitr.2008040103

Chicago

McCoy, Jason, and Johannes Sarx. "Offshoring in the Pharmaceutical Industry," Journal of Information Technology Research (JITR) 1, no.2: 38-53. http://doi.org/10.4018/jitr.2008040103

Export Reference

Mendeley
Favorite Full-Issue Download

Abstract

Offshoring has been adopted as a tool for reducing costs and for gaining strategic advantages by financial services, software development, and other competitive industries. For a variety of reasons, the pharmaceutical industry has been slow to take advantage of the benefits that offshoring can provide. The purpose of this article is to explore the internal and exogenous factors motivating global pharmaceutical firms to increase and expand their sourcing activities. And, instead of discussing global sourcing in general, India has been analyzed as a unique and explanatory case study for this new, emerging trend. The reasons behind this decision include India’s position as a renowned global IT hub, the country’s “home grown” biotechnology and biopharmaceutical industries, the numerous strategic partnerships and offshoring relationships between global and Indian firms, as well as its significant advances in IT and information management.

Request Access

You do not own this content. Please login to recommend this title to your institution's librarian or purchase it from the IGI Global bookstore.